Your browser doesn't support javascript.
loading
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma.
Borgeaud, Maxime; Kim, Floryane; Friedlaender, Alex; Lococo, Filippo; Addeo, Alfredo; Minervini, Fabrizio.
Affiliation
  • Borgeaud M; Oncology Department, University Hospital Geneva (HUG), 1205 Geneva, Switzerland.
  • Kim F; Oncology Department, University Hospital Geneva (HUG), 1205 Geneva, Switzerland.
  • Friedlaender A; Oncology Department, University Hospital Geneva (HUG), 1205 Geneva, Switzerland.
  • Lococo F; Oncology Department, Clinique Générale Beaulieu, 1206 Geneva, Switzerland.
  • Addeo A; Department of Thoracic Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Minervini F; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.
J Clin Med ; 12(5)2023 Feb 22.
Article in En | MEDLINE | ID: mdl-36902544
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland